Concepts and methods to access novel antibiotics from actinomycetes

Antibiotics

Volumn 7, Issue 2, 2018, Pages

  Hug, Joachim J ^a,b   Bader, Chantal D ^a,b   Remškar, Maja ^a,b   Cirnski, Katarina ^a,b   Müller, Rolf ^a,b  

^a SAARLAND UNIVERSITY   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Dereplication; Genome mining; Metabolomics; Metagenomics; Natural products; Rare actinomycetes

Indexed keywords

ANTIBIOTIC AGENT; GREEN FLUORESCENT PROTEIN;

ACTINOBACTERIA; AGAR DIFFUSION; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BURKHOLDERIA THAILANDENSIS; DNA MODIFICATION; DNA SEQUENCE; ENDOPHYTE; ENDOPHYTIC FUNGUS; ENZYME ACTIVITY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE CLUSTER; GENE EXPRESSION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLOMICS; METAGENOMICS; MICROBIAL COMMUNITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW;

EID: 85047990193     PISSN: None     EISSN: 20796382     Source Type: Journal    
DOI: 10.3390/antibiotics7020044     Document Type: Review

References (304)

1. World Health Organization. Global Antimicrobial Resistance Surveillance System (GLASS) Report: Early Implementation. Available online: http://apps.who.int/iris/bitstream/handle/10665/259744/9789241513449-eng.pdf;jsessionid=97E045EBFE3B29F286CBA3EE8360F0D1?sequence=1 (accessed on 31 January 2018).
2. Aminov, R.I. A brief history of the antibiotic era: Lessons learned and challenges for the future. Front. Microbiol. 2010, 1. [CrossRef] [PubMed]
3. De Lima Procópio, R.E.; da Silva, I.R.; Martins, M.K.; de Azevedo, J.L.; de Araújo, J.M. Antibiotics produced by Streptomyces. Braz. J. Infect. Dis. 2012, 16, 466–471. [CrossRef] [PubMed]
4. Li, J.W.-H.; Vederas, J.C. Drug discovery and natural products: End of an era or an endless frontier? Science 2009, 325, 161–165. [CrossRef] [PubMed]
5. Luzhetskyy, A.; Pelzer, S.; Bechthold, A. The future of natural products as a source of new antibiotics. Curr. Opin. Investig. Drugs 2007, 8, 608–613. [PubMed]
6. Thumar, J.T.; Dhulia, K.; Singh, S.P. Isolation and partial purification of an antimicrobial agent from halotolerant alkaliphilic Streptomyces aburaviensis strain Kut-8. World J. Microbiol. Biotechnol. 2010, 26, 2081–2087. [CrossRef]
7. Hozzein, W.N.; Rabie, W.; Ali, M.I.A. Screening the Egyptian desert actinomycetes as candidates for new antimicrobial compounds and identification of a new desert Streptomyces strain. Afr. J. Biotechnol. 2011, 10, 2295–2301.
8. Tiwari, K.; Gupta, R.K. Studies in Natural Products Chemistry. Bioactive Metabolites from Rare Actinomycetes; Elsevier: New York, NY, USA, 2014; Chapter 14.
9. Bister, B.; Bischoff, D.; Strobele, M.; Riedlinger, J.; Reicke, A.; Wolter, F.; Bull, A.T.; Zahner, H.; Fiedler, H.P.; Sussmuth, R.D. Abyssomicin C—A polycyclic antibiotic from a marine Verrucosispora strain as an inhibitor of the p-aminobenzoic acid/tetrahydrofolate biosynthesis pathway. Angew. Chem. Int. Ed. Engl. 2004, 43, 2574–2576. [CrossRef] [PubMed]
10. Fiedler, H.-P.; Bruntner, C.; Riedlinger, J.; Bull, A.T.; Knutsen, G.; Goodfellow, M.; Jones, A.; Maldonado, L.; Pathom-Aree, W.; Beil, W.; et al. Proximicin A, B and C, novel aminofuran antibiotic and anticancer compounds isolated from marine strains of the actinomycete Verrucosispora. J. Antibiot. 2008, 61, 158–163. [CrossRef] [PubMed]
11. Genilloud, O.; Gonzalez, I.; Salazar, O.; Martin, J.; Tormo, J.R.; Vicente, F. Current approaches to exploit actinomycetes as a source of novel natural products. J. Ind. Microbiol. Biotechnol. 2011, 38, 375–389. [CrossRef] [PubMed]
12. Subramani, R.; Aalbersberg, W. Culturable rare Actinomycetes: Diversity, isolation and marine natural product discovery. Appl. Microbiol. Biotechnol. 2013, 97, 9291–9321. [CrossRef] [PubMed]
13. Bentley, S.D.; Chater, K.F.; Cerdeño-Tárraga, A.-M.; Challis, G.L.; Thomson, N.R.; James, K.D.; Harris, D.E.; Quail, M.A.; Kieser, H.; Harper, D.; et al. Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature 2002, 417, 141–147. [CrossRef] [PubMed]
14. Vartoukian, S.R.; Palmer, R.M.; Wade, W.G. Strategies for culture of “unculturable” bacteria. FEMS Microbiol. Lett. 2010, 309, 1–7. [CrossRef] [PubMed]
15. Hoffmann, T.; Krug, D.; Bozkurt, N.; Duddela, S.; Jansen, R.; Garcia, R.; Gerth, K.; Steinmetz, H.; Müller, R. Correlating chemical diversity with taxonomic distance for discovery of natural products in myxobacteria. Nat. Commun. 2018, 9. [CrossRef] [PubMed]
16. Krug, D.; Müller, R. Secondary metabolomics: The impact of mass spectrometry-based approaches on the discovery and characterization of microbial natural products. Nat. Prod. Rep. 2014, 31, 768–783. [CrossRef] [PubMed]
17. Wenzel, S.C.; Müller, R. The impact of genomics on the exploitation of the myxobacterial secondary metabolome. Nat. Prod. Rep. 2009, 26, 1385–1407. [CrossRef] [PubMed]
18. Bode, H.B.; Müller, R. The impact of bacterial genomics on natural product research. Angew. Chem. Int. Ed. Engl. 2005, 44, 6828–6846. [CrossRef] [PubMed]
19. Challinor, V.L.; Bode, H.B. Bioactive natural products from novel microbial sources. Ann. N. Y. Acad. Sci. 2015, 1354, 82–97. [CrossRef] [PubMed]
20. Lam, K.S. Discovery of novel metabolites from marine actinomycetes. Curr. Opin. Microbiol. 2006, 9, 245–251. [CrossRef] [PubMed]
21. Mahajan, G.B.; Balachandran, L. Sources of antibiotics: Hot springs. Biochem. Pharmacol. 2017, 134, 35–41. [CrossRef] [PubMed]
22. Passari, A.K.; Mishra, V.K.; Saikia, R.; Gupta, V.K.; Singh, B.P. Isolation, abundance and phylogenetic affiliation of endophytic actinomycetes associated with medicinal plants and screening for their in vitro antimicrobial biosynthetic potential. Front. Microbiol. 2015, 6. [CrossRef] [PubMed]
23. Blunt, J.W.; Carroll, A.R.; Copp, B.R.; Davis, R.A.; Keyzers, R.A.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2018, 35, 8–53. [CrossRef] [PubMed]
24. Tiwari, K.; Gupta, R.K. Diversity and isolation of rare actinomycetes: An overview. Crit. Rev. Microbiol. 2013, 39, 256–294. [CrossRef] [PubMed]
25. Kurtboke, D.I.; French, J.R.J. Use of phage battery to investigate the actinofloral layers of termite gut microflora. J. Appl. Microbiol. 2007, 103, 722–734. [CrossRef] [PubMed]
26. Rateb, M.E.; Houssen, W.E.; Harrison, W.T.A.; Deng, H.; Okoro, C.K.; Asenjo, J.A.; Andrews, B.A.; Bull, A.T.; Goodfellow, M.; Ebel, R.; et al. Diverse metabolic profiles of a Streptomyces strain isolated from a hyper-arid environment. J. Nat. Prod. 2011, 74, 1965–1971. [CrossRef] [PubMed]
27. Okoro, C.K.; Brown, R.; Jones, A.L.; Andrews, B.A.; Asenjo, J.A.; Goodfellow, M.; Bull, A.T. Diversity of culturable actinomycetes in hyper-arid soils of the Atacama Desert, Chile. Anton. Leeuwenhoek 2009, 95, 121–133. [CrossRef] [PubMed]
28. Hadj Rabia-Boukhalfa, Y.; Eveno, Y.; Karama, S.; Selama, O.; Lauga, B.; Duran, R.; Hacène, H.; Eparvier, V. Isolation, purification and chemical characterization of a new angucyclinone compound produced by a new halotolerant Nocardiopsis sp. HR-4 strain. World J. Microbiol. Biotechnol. 2017, 33. [CrossRef] [PubMed]
29. Duraipandiyan, V.; Al-Dhabi, N.A.; Ignacimuthu, S. New antimicrobial anthraquinone 6,61-bis (1,5,7-trihydroxy-3-hydroxymethylanthraquinone) isolated from Streptomyces sp. isolate ERI-26. Saudi J. Biol. Sci. 2016, 23, 731–735. [CrossRef] [PubMed]
30. Arasu, M.V.; Duraipandiyan, V.; Agastian, P.; Ignacimuthu, S. Antimicrobial activity of Streptomyces spp. ERI-26 recovered from Western Ghats of Tamil Nadu. J. Mycol. Med. 2008, 18, 147–153. [CrossRef]
31. Stewart, E.J. Growing Unculturable Bacteria. J. Bacteriol. 2012, 194, 4151–4160. [CrossRef] [PubMed]
32. Bollmann, A.; Lewis, K.; Epstein, S.S. Incubation of environmental samples in a diffusion chamber increases the diversity of recovered isolates. Appl. Environ. Microbiol. 2007, 73, 6386–6390. [CrossRef] [PubMed]
33. Nichols, D.; Cahoon, N.; Trakhtenberg, E.M.; Pham, L.; Mehta, A.; Belanger, A.; Kanigan, T.; Lewis, K.; Epstein, S.S. Use of iChip for high-throughput in situ cultivation of “uncultivable” microbial species. Appl. Environ. Microbiol. 2010, 76, 2445–2450. [CrossRef] [PubMed]
34. Peoples, A.J.; Zhang, Q.; Millett, W.P.; Rothfeder, M.T.; Pescatore, B.C.; Madden, A.A.; Ling, L.L.; Moore, C.M. Neocitreamicins I and II, novel antibiotics with activity against methicillin resistant Staphylococcus aureus and vancomycin-resistant Enterococci. J. Antibiot. 2008, 61, 457–463. [CrossRef] [PubMed]
35. Kaeberlein, T.; Lewis, K.; Epstein, S.S. Isolating “uncultivable” microorganisms in pure culture in a simulated natural environment. Science 2002, 296, 1127–1129. [CrossRef] [PubMed]
36. Peoples, A.; Zhang, Q.; Moore, C.; Ling, L.; Rothfeder, M.; Lewis, K. Macrolactam Compounds. Patent WO2009026527A1, 17 January 2012.
37. Gavrish, E.; Sit, C.S.; Cao, S.; Kandror, O.; Spoering, A.; Peoples, A.; Ling, L.; Fetterman, A.; Hughes, D.; Bissell, A.; et al. Lassomycin, a ribosomally synthesized cyclic peptide, kills Mycobacterium tuberculosis by targeting the ATP-dependent protease ClpC1P1P2. Chem. Biol. 2014, 21, 509–518. [CrossRef] [PubMed]
38. Ling, L.L.; Schneider, T.; Peoples, A.J.; Spoering, A.L.; Engels, I.; Conlon, B.P.; Mueller, A.; Schäberle, T.F.; Hughes, D.E.; Epstein, S.; et al. A new antibiotic kills pathogens without detectable resistance. Nature 2015, 517, 455–459. [CrossRef] [PubMed]
39. Goers, L.; Freemont, P.; Polizzi, K.M. Co-culture systems and technologies: Taking synthetic biology to the next level. J. R. Soc. Interface 2014, 11. [CrossRef] [PubMed]
40. Dashti, Y.; Grkovic, T.; Abdelmohsen, U.R.; Hentschel, U.; Quinn, R.J. Production of induced secondary metabolites by a co-culture of sponge-associated actinomycetes, Actinokineospora sp. EG49 and Nocardiopsis sp. RV 163. Mar. Drugs 2014, 12, 3046–3059. [CrossRef] [PubMed]
41. Zengler, K.; Toledo, G.; Rappe, M.; Elkins, J.; Mathur, E.J.; Short, J.M.; Keller, M. Cultivating the uncultured. Proc. Natl. Acad. Sci. USA 2002, 99, 15681–15686. [CrossRef] [PubMed]
42. Zengler, K.; Walcher, M.; Clark, G.; Haller, I.; Toledo, G.; Holland, T.; Mathur, E.J.; Woodnutt, G.; Short, J.M.; Keller, M. High-throughput cultivation of microorganisms using microcapsules. In Environmental Microbiology; Leadbetter, J.R., Ed.; Elsevier Academic Press: Amsterdam, The Netherlands; Boston, MA, USA, 2005; pp. 124–130.
43. Ben-Dov, E.; Kramarsky-Winter, E.; Kushmaro, A. An in situ method for cultivating microorganisms using a double encapsulation technique. FEMS Microbiol. Ecol. 2009, 68, 363–371. [CrossRef] [PubMed]
44. Bomar, L.; Maltz, M.; Colston, S.; Graf, J. Directed culturing of microorganisms using metatranscriptomics. mBio 2011, 2. [CrossRef] [PubMed]
45. Morris, J.J.; Kirkegaard, R.; Szul, M.J.; Johnson, Z.I.; Zinser, E.R. Facilitation of robust growth of prochlorococcus colonies and dilute liquid cultures by “helper” heterotrophic bacteria. Appl. Environ. Microbiol. 2008, 74, 4530–4534. [CrossRef] [PubMed]
46. Tanaka, Y.; Hanada, S.; Manome, A.; Tsuchida, T.; Kurane, R.; Nakamura, K.; Kamagata, Y. Catellibacterium nectariphilum gen. nov., sp. nov., which requires a diffusible compound from a strain related to the genus Sphingomonas for vigorous growth. Int. J. Syst. Evol. Microbiol. 2004, 54, 955–959. [CrossRef] [PubMed]
47. Kim, K.; Kim, J.-J.; Masui, R.; Kuramitsu, S.; Sung, M.-H. A commensal symbiotic interrelationship for the growth of Symbiobacterium toebii with its partner bacterium, Geobacillus toebii. BMC Res. Notes 2011, 4. [CrossRef] [PubMed]
48. Morris, J.J.; Lenski, R.E.; Zinser, E.R. The Black Queen Hypothesis: Evolution of dependencies through adaptive gene loss. mBio 2012, 3, e00036-12. [CrossRef] [PubMed]
49. Schofield, M.M.; Jain, S.; Porat, D.; Dick, G.J.; Sherman, D.H. Identification and analysis of the bacterial endosymbiont specialized for production of the chemotherapeutic natural product ET-743. Environ. Microbiol. 2015, 17, 3964–3975. [CrossRef] [PubMed]
50. Rashad, F.M.; Fathy, H.M.; El-Zayat, A.S.; Elghonaimy, A.M. Isolation and characterization of multifunctional Streptomyces species with antimicrobial, nematicidal and phytohormone activities from marine environments in Egypt. Microbiol. Res. 2015, 175, 34–47. [CrossRef] [PubMed]
51. Bode, H.B.; Bethe, B.; Höfs, R.; Zeeck, A. Big effects from small changes: Possible ways to explore nature’s chemical diversity. ChemBioChem 2002, 3, 619–627. [CrossRef]
52. Engelhardt, K.; Degnes, K.F.; Kemmler, M.; Bredholt, H.; Fjaervik, E.; Klinkenberg, G.; Sletta, H.; Ellingsen, T.E.; Zotchev, S.B. Production of a new thiopeptide antibiotic, TP-1161, by a marine Nocardiopsis species. Appl. Environ. Microbiol. 2010, 76, 4969–4976. [CrossRef] [PubMed]
53. Dufour, C.; Wink, J.; Kurz, M.; Kogler, H.; Olivan, H.; Sablé, S.; Heyse, W.; Gerlitz, M.; Toti, L.; Nußer, A.; et al. Isolation and structural elucidation of armeniaspirols A–C: Potent antibiotics against Gram-positive pathogens. Chem. Eur. J. 2012, 18, 16123–16128. [CrossRef] [PubMed]
54. Ma, J.; Huang, H.; Xie, Y.; Liu, Z.; Zhao, J.; Zhang, C.; Jia, Y.; Zhang, Y.; Zhang, H.; Zhang, T.; et al. Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents. Nat. Commun. 2017, 8. [CrossRef] [PubMed]
55. Boubetra, D.; Sabaou, N.; Zitouni, A.; Bijani, C.; Lebrihi, A.; Mathieu, F. Taxonomy and chemical characterization of new antibiotics produced by Saccharothrix SA198 isolated from a Saharan soil. Microbiol. Res. 2013, 168, 223–230. [CrossRef] [PubMed]
56. Lee, L.-H.; Cheah, Y.-K.; Mohd Sidik, S.; Ab Mutalib, N.-S.; Tang, Y.-L.; Lin, H.-P.; Hong, K. Molecular characterization of Antarctic actinobacteria and screening for antimicrobial metabolite production. World J. Microbiol. Biotechnol. 2012, 28, 2125–2137. [CrossRef] [PubMed]
57. Liu, L.; Salam, N.; Jiao, J.-Y.; Jiang, H.-C.; Zhou, E.-M.; Yin, Y.-R.; Ming, H.; Li, W.-J. Diversity of culturable thermophilic Actinobacteria in hot springs in Tengchong, china and studies of their biosynthetic gene profiles. Microb. Ecol. 2016, 72, 150–162. [CrossRef] [PubMed]
58. Silva-Lacerda, G.R.; Santana, R.C.F.; Vicalvi-Costa, M.C.V.; Solidônio, E.G.; Sena, K.X.F.R.; Lima, G.M.S.; Araújo, J.M. Antimicrobial potential of actinobacteria isolated from the rhizosphere of the Caatinga biome plant Caesalpinia pyramidalis Tul. Genet. Mol. Res. 2016, 15. [CrossRef] [PubMed]
59. Hamm, P.S.; Caimi, N.A.; Northup, D.E.; Valdez, E.W.; Buecher, D.C.; Dunlap, C.A.; Labeda, D.P.; Lueschow, S.; Porras-Alfaro, A. Western bats as a reservoir of novel Streptomyces species with antifungal activity. Appl. Environ. Microbiol. 2017, 83. [CrossRef] [PubMed]
60. Braña, A.F.; Sarmiento-Vizcaíno, A.; Pérez-Victoria, I.; Otero, L.; Fernández, J.; Palacios, J.J.; Martín, J.; De La Cruz, M.; Díaz, C.; Vicente, F.; et al. Branimycins B and C, antibiotics produced by the abyssal actinobacterium Pseudonocardia carboxydivorans M-227. J. Nat. Prod. 2017, 80, 569–573. [CrossRef] [PubMed]
61. Xu, J.-H.; Gu, K.-B.; Zhang, D.-J.; Li, Y.-G.; Tian, L. Ghanamycins A and B, two novel -butyrolactones from marine-derived Streptomyces ghanaensis TXC6-16. J. Antibiot. 2017, 70, 733–736 [CrossRef] [PubMed]
62. Niu, S.; Li, S.; Chen, Y.; Tian, X.; Zhang, H.; Zhang, G.; Zhang, W.; Yang, X.; Zhang, S.; Ju, J.; et al. Lobophorins E and F, new spirotetronate antibiotics from a South China Sea-derived Streptomyces sp. SCSIO01127. J. Antibiot. 2011, 64, 711–716. [CrossRef] [PubMed]
63. Fu, P.; MacMillan, J.B. Spithioneines A and B, two new bohemamine derivatives possessing ergothioneine moiety from a marine-derived Streptomyces spinoverrucosus. Org. Lett. 2015, 17, 3046–3049. [CrossRef] [PubMed]
64. Keller, S.; Nicholson, G.; Drahl, C.; Sorensen, E.; Fiedler, H.-P.; Sussmuth, R.D. Abyssomicins G and H and atrop-abyssomicin C from the marine Verrucosispora strain AB-18-032. J. Antibiot. 2007, 60, 391–394. [CrossRef] [PubMed]
65. Igarashi, Y.; Yu, L.; Miyanaga, S.; Fukuda, T.; Saitoh, N.; Sakurai, H.; Saiki, I.; Alonso-Vega, P.; Trujillo, M.E. Abyssomicin I, a modified polycyclic polyketide from Streptomyces sp. CHI39. J. Nat. Prod. 2010, 73, 1943–1946. [CrossRef] [PubMed]
66. Niu, X.-M.; Li, S.-H.; Gorls, H.; Schollmeyer, D.; Hilliger, M.; Grabley, S.; Sattler, I. Abyssomicin E, a highly functionalized polycyclic metabolite from Streptomyces species. Org. Lett. 2007, 9, 2437–2440. [CrossRef] [PubMed]
67. Feling, R.H.; Buchanan, G.O.; Mincer, T.J.; Kauffman, C.A.; Jensen, P.R.; Fenical, W. Salinosporamide A: A highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus Salinospora. Angew. Chem. Int. Ed. Engl. 2003, 42, 355–357. [CrossRef] [PubMed]
68. Stadler, M.; Bitzer, J.; Mayer-Bartschmid, A.; Muller, H.; et-Buchholz, J.; Gantner, F.; Tichy, H.V.; Reinemer, P.; Bacon, K.B. Cinnabaramides A–G: Analogues of lactacystin and salinosporamide from a terrestrial streptomycete. J. Nat. Prod. 2007, 70, 246–252. [CrossRef] [PubMed]
69. Messaoudi, O.; Bendahou, M.; Benamar, I.; Abdelwouhid, D.-E. Identification and preliminary characterization of non-polyene antibiotics secreted by new strain of actinomycete isolated from sebkha of Kenadsa, Algeria. Asian Pac. J. Trop. Biomed. 2015, 5, 438–445. [CrossRef]
70. Shin, B.; Kim, B.-Y.; Cho, E.; Oh, K.-B.; Shin, J.; Goodfellow, M.; Oh, D.-C. Actinomadurol, an antibacterial norditerpenoid from a rare Actinomycete, Actinomadura sp. KC 191. J. Nat. Prod. 2016, 79, 1886–1890. [CrossRef] [PubMed]
71. Al-Dhabi, N.A.; Esmail, G.A.; Duraipandiyan, V.; Valan Arasu, M.; Salem-Bekhit, M.M. Isolation, identification and screening of antimicrobial thermophilic Streptomyces sp. Al-Dhabi-1 isolated from Tharban hot spring, Saudi Arabia. Extremophiles 2016, 20, 79–90. [CrossRef] [PubMed]
72. Strobel, G.; Daisy, B. Bioprospecting for microbial endophytes and their natural products. Microbiol. Mol. Biol. Rev. 2003, 67, 491–502. [CrossRef] [PubMed]
73. Matsumoto, A.; Takahashi, Y. Endophytic actinomycetes: Promising source of novel bioactive compounds. J. Antibiot. 2017, 70, 514–519. [CrossRef] [PubMed]
74. Chagas, F.O.; Ruzzini, A.C.; Bacha, L.V.; Samborskyy, M.; Conti, R.; Pessotti, R.C.; de Oliveira, L.G.; Clardy, J.; Pupo, M.T. Genome sequence of Streptomyces sp. strain RTd22, an endophyte of the Mexican sunflower. Genome Announc. 2016, 4. [CrossRef] [PubMed]
75. Barke, J.; Seipke, R.F.; Grüschow, S.; Heavens, D.; Drou, N.; Bibb, M.J.; Goss, R.J.M.; Yu, D.W.; Hutchings, M.I. A mixed community of actinomycetes produce multiple antibiotics for the fungus farming ant Acromyrmex octospinosus. BMC Biol. 2010, 8. [CrossRef] [PubMed]
76. Oh, D.-C.; Poulsen, M.; Currie, C.R.; Clardy, J. Sceliphrolactam, a polyene macrocyclic lactam from a wasp-associated Streptomyces sp. Org. Lett. 2011, 13, 752–755. [CrossRef] [PubMed]
77. Beemelmanns, C.; Ramadhar, T.R.; Kim, K.H.; Klassen, J.L.; Cao, S.; Wyche, T.P.; Hou, Y.; Poulsen, M.; Bugni, T.S.; Currie, C.R.; et al. Macrotermycins A–D, glycosylated macrolactams from a termite-associated Amycolatopsis sp. M 39. Org. Lett. 2017, 19, 1000–1003. [CrossRef] [PubMed]
78. Kim, K.H.; Ramadhar, T.R.; Beemelmanns, C.; Cao, S.; Poulsen, M.; Currie, C.R.; Clardy, J. Natalamycin A, an ansamycin from a termite-associated Streptomyces sp. Chem. Sci. 2014, 5, 4333–4338. [CrossRef] [PubMed]
79. Sit, C.S.; Ruzzini, A.C.; van Arnam, E.B.; Ramadhar, T.R.; Currie, C.R.; Clardy, J. Variable genetic architectures produce virtually identical molecules in bacterial symbionts of fungus-growing ants. Proc. Natl. Acad. Sci. USA 2015, 112, 13150–13154. [CrossRef] [PubMed]
80. Nettleton, D.E.; Doyle, T.W.; Krishnan, B.; Matsumoto, G.K.; Clardy, J. Isolation and structure of rebeccamycin—A new antitumor antibiotic from Nocardia aerocoligenes. Tetrahedron Lett. 1985, 26, 4011–4014. [CrossRef]
81. Van Arnam, E.B.; Ruzzini, A.C.; Sit, C.S.; Currie, C.R.; Clardy, J. A rebeccamycin analog provides plasmid-encoded niche defense. J. Am. Chem. Soc. 2015, 137, 14272–14274. [CrossRef] [PubMed]
82. Wyche, T.P.; Ruzzini, A.C.; Schwab, L.; Currie, C.R.; Clardy, J. Tryptorubin A: A polycyclic peptide from a fungus-derived streptomycete. J. Am. Chem. Soc. 2017, 139, 12899–12902. [CrossRef] [PubMed]
83. Pettit, R.K. Culturability and secondary metabolite diversity of extreme microbes: Expanding contribution of deep sea and deep-sea vent microbes to natural product discovery. Mar. Biotechnol. 2011, 13, 1–11. [CrossRef] [PubMed]
84. Wilson, Z.E.; Brimble, M.A. Molecules derived from the extremes of life. Nat. Prod. Rep. 2009, 26, 44–71. [CrossRef] [PubMed]
85. Brady, S.F.; Simmons, L.; Kim, J.H.; Schmidt, E.W. Metagenomic approaches to natural products from free-living and symbiotic organisms. Nat. Prod. Rep. 2009, 26, 1488–1503. [CrossRef] [PubMed]
86. Techtmann, S.M.; Hazen, T.C. Metagenomic applications in environmental monitoring and bioremediation. J. Ind. Microbiol. Biotechnol. 2016, 43, 1345–1354. [CrossRef] [PubMed]
87. Kavitha, S.; Selvakumar, R.; Sathishkumar, M.; Swaminathan, K.; Lakshmanaperumalsamy, P.; Singh, A.; Jain, S.K. Nitrate removal using Brevundimonas diminuta MTCC 8486 from ground water. Water Sci. Technol. 2009, 60, 517–524. [CrossRef] [PubMed]
88. Green, S.J.; Prakash, O.; Jasrotia, P.; Overholt, W.A.; Cardenas, E.; Hubbard, D.; Tiedje, J.M.; Watson, D.B.; Schadt, C.W.; Brooks, S.C.; et al. Denitrifying bacteria from the genus Rhodanobacter dominate bacterial communities in the highly contaminated subsurface of a nuclear legacy waste site. Appl. Environ. Microbiol. 2012, 78, 1039–1047. [CrossRef] [PubMed]
89. Dubinsky, E.A.; Conrad, M.E.; Chakraborty, R.; Bill, M.; Borglin, S.E.; Hollibaugh, J.T.; Mason, O.U.; Piceno, Y.M.; Reid, F.C.; Stringfellow, W.T.; et al. Succession of hydrocarbon-degrading bacteria in the aftermath of the deepwater horizon oil spill in the gulf of Mexico. Environ. Sci. Technol. 2013, 47, 10860–10867. [CrossRef] [PubMed]
90. Lok, C. Mining the microbial dark matter. Nature 2015, 522, 270–273. [CrossRef] [PubMed]
91. Brady, S.F.; Chao, C.J.; Handelsman, J.; Clardy, J. Cloning and heterologous expression of a natural product biosynthetic gene cluster from eDNA. Org. Lett. 2001, 3, 1981–1984. [CrossRef] [PubMed]
92. Owen, J.G.; Charlop-Powers, Z.; Smith, A.G.; Ternei, M.A.; Calle, P.Y.; Reddy, B.V.B.; Montiel, D.; Brady, S.F. Multiplexed metagenome mining using short DNA sequence tags facilitates targeted discovery of epoxyketone proteasome inhibitors. Proc. Natl. Acad. Sci. USA 2015, 112, 4221–4226. [CrossRef] [PubMed]
93. Katz, M.; Hover, B.M.; Brady, S.F. Culture-independent discovery of natural products from soil metagenomes. J. Ind. Microbiol. Biotechnol. 2016, 43, 129–141. [CrossRef] [PubMed]
94. Altaee, N.; Jawad, M.; Hameed, I. Characterization of metabolites produced by E. coli and analysis of its chemical compounds using GC-MS. IJCPR 2017, 7, 393–399.
95. Wexler, M.; Johnston, A. W.B. Wide host-range cloning for functional metagenomics. In Metagenomics: Methods and Protocols; Streit, W.R., Daniel, R., Eds.; Humana: London, UK; Springer: New York, NY, USA, 2010; pp. 77–96.
96. Gabor, E.M.; Alkema, W.B.; Janssen, D.B. Quantifying the accessibility of the metagenome by random expression cloning techniques. Environ. Microbiol. 2004, 6, 879–886. [CrossRef] [PubMed]
97. Stevens, D.C.; Conway, K.R.; Pearce, N.; Villegas-Penaranda, L.R.; Garza, A.G.; Boddy, C.N. Alternative sigma factor over-expression enables heterologous expression of a type II polyketide biosynthetic pathway in Escherichia coli. PLoS ONE 2013, 8, e64858. [CrossRef] [PubMed]
98. Pfeifer, B.A.; Admiraal, S.J.; Gramajo, H.; Cane, D.E.; Khosla, C. Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli. Science 2001, 291, 1790–1792. [CrossRef] [PubMed]
99. Boddy, C.N.; Hotta, K.; Tse, M.L.; Watts, R.E.; Khosla, C. Precursor-directed biosynthesis of epothilone in Escherichia coli. J. Am. Chem. Soc. 2004, 126, 7436–7437. [CrossRef] [PubMed]
100. Watanabe, K.; Hotta, K.; Praseuth, A.P.; Koketsu, K.; Migita, A.; Boddy, C.N.; Wang, C.C.; Oguri, H.; Oikawa, H. Total biosynthesis of antitumor nonribosomal peptides in Escherichia coli. Nat. Chem. Biol. 2006, 2, 423–428. [CrossRef] [PubMed]
101. Ortega, M.A.; Van Der Donk, W.A. New insights into the biosynthetic logic of ribosomally synthesized and post-translationally modified peptide natural products. Cell Chem. Biol. 2016, 23, 31–44. [CrossRef] [PubMed]
102. Ongley, S.; Bian, X.; Neilan, B.A.; Müller, R. Recent advances in the heterologous expression of microbial natural product biosynthetic pathways. Nat. Prod. Rep. 2013, 30, 1121–1138. [CrossRef] [PubMed]
103. Wenzel, S.C. Biosynthesis and Heterologous Production of Myxobacterial Secondary Metabolites. Ph.D. Thesis, Fachbereich Biowissenschaftern und Psychologie, Technische Carolo-Wilhemina-Universität, Braunschweig, Germany, 2005.
104. Ferrari, B.C.; Binnerup, S.J.; Gillings, M. Microcolony cultivation on a soil substrate membrane system selects for previously uncultured soil bacteria. Appl. Environ. Microbiol. 2005, 71, 8714–8720. [CrossRef] [PubMed]
105. Cueto, M.; Jensen, P.R.; Kauffman, C.; Fenical, W.; Lobkovsky, E.; Clardy, J. Pestalone, a new antibiotic produced by a marine fungus in response to bacterial challenge. J. Nat. Prod. 2001, 64, 1444–1446. [CrossRef] [PubMed]
106. Moore, J.M.; Bradshaw, E.; Seipke, R.F.; Hutchings, M.I.; McArthur, M. Use and discovery of chemical elicitors that stimulate biosynthetic gene clusters in Streptomyces bacteria. Methods Enzymol. 2012, 517, 367–385. [PubMed]
107. Montiel, D.; Kang, H.-S.; Chang, F.-Y.; Charlop-Powers, Z.; Brady, S.F. Yeast homologous recombination-based promoter engineering for the activation of silent natural product biosynthetic gene clusters. Proc. Natl. Acad. Sci. USA 2015, 112, 8953–8958. [CrossRef] [PubMed]
108. Chang, F.-Y.; Ternei, M.A.; Calle, P.Y.; Brady, S.F. Discovery and synthetic refactoring of tryptophan dimer gene clusters from the environment. J. Am. Chem. Soc. 2013, 135, 17906–17912. [CrossRef] [PubMed]
109. Trindade, M.; van Zyl, L.J.; Navarro-Fernández, J.; Abd Elrazak, A. Targeted metagenomics as a tool to tap into marine natural product diversity for the discovery and production of drug candidates. Front. Microbiol. 2015, 6. [CrossRef] [PubMed]
110. Williamson, L.L.; Borlee, B.R.; Schloss, P.D.; Guan, C.; Allen, H.K.; Handelsman, J. Intracellular screen to identify metagenomic clones that induce or inhibit a quorum-sensing biosensor. Appl. Environ. Microbiol. 2005, 71, 6335–6344. [CrossRef] [PubMed]
111. Uchiyama, T.; Abe, T.; Ikemura, T.; Watanabe, K. Substrate-induced gene-expression screening of environmental metagenome libraries for isolation of catabolic genes. Nat. Biotechnol. 2005, 23, 88–93. [CrossRef] [PubMed]
112. Lim, H.K.; Chung, E.J.; Kim, J.-C.; Choi, G.J.; Jang, K.S.; Chung, Y.R.; Cho, K.Y.; Lee, S.-W. Characterization of a forest soil metagenome clone that confers indirubin and indigo production on Escherichia coli. Appl. Environ. Microbiol. 2005, 71, 7768–7777. [CrossRef] [PubMed]
113. Brady, S.F.; Chao, C.J.; Clardy, J. New natural product families from an environmental DNA (eDNA) gene cluster. J. Am. Chem. Soc. 2002, 124, 9968–9969. [CrossRef] [PubMed]
114. Gillespie, D.E.; Brady, S.F.; Bettermann, A.D.; Cianciotto, N.P.; Liles, M.R.; Rondon, M.R.; Clardy, J.; Goodman, R.M.; Handelsman, J. Isolation of antibiotics turbomycin A and B from a metagenomic library of soil microbial DNA. Appl. Environ. Microbiol. 2002, 68, 4301–4306. [CrossRef] [PubMed]
115. Zhang, M.M.; Qiao, Y.; Ang, E.L.; Zhao, H. Using natural products for drug discovery: The impact of the genomics era. Expert Opin. Drug Discov. 2017, 12, 475–487. [CrossRef] [PubMed]
116. Ferrer, M.; Beloqui, A.; Vieites, J.M.; Guazzaroni, M.E.; Berger, I.; Aharoni, A. Interplay of metagenomics and in vitro compartmentalization. Microb. Biotechnol. 2009, 2, 31–39. [CrossRef] [PubMed]
117. Owen, J.G.; Robins, K.J.; Parachin, N.S.; Ackerley, D.F. A functional screen for recovery of 4’-phosphopantetheinyl transferase and associated natural product biosynthesis genes from metagenome libraries. Environ. Microbiol. 2012, 14, 1198–1209. [CrossRef] [PubMed]
118. Beld, J.; Sonnenschein, E.C.; Vickery, C.R.; Noel, J.P.; Burkart, M.D. The phosphopantetheinyl transferases: Catalysis of a post-translational modification crucial for life. Nat. Prod. Rep. 2013, 31, 61–108. [CrossRef] [PubMed]
119. Bitok, J.K.; Lemetre, C.; Ternei, M.A.; Brady, S.F. Identification of biosynthetic gene clusters from metagenomic libraries using PPTase complementation in a Streptomyces host. FEMS Microbiol. Lett. 2017, 364. [CrossRef] [PubMed]
120. Gaitatzis, N.; Kunze, B.; Müller, R. In vitro reconstitution of the myxochelin biosynthetic machinery of Stigmatella aurantiaca Sg a15: Biochemical characterization of a reductive release mechanism from nonribosomal peptide synthetases. Proc. Natl. Acad. Sci. USA 2001, 98, 11136–11141. [CrossRef] [PubMed]
121. Weber, T.; Blin, K.; Duddela, S.; Krug, D.; Kim, H.U.; Bruccoleri, R.; Lee, S.Y.; Fischbach, M.A.; Müller, R.; Wohlleben, W.; et al. antiSMASH 3.0—A comprehensive resource for the genome mining of biosynthetic gene clusters. Nucleic Acids Res. 2015, 43, W237–W243. [CrossRef] [PubMed]
122. Blin, K.; Wolf, T.; Chevrette, M.G.; Lu, X.; Schwalen, C.J.; Kautsar, S.A.; Suarez Duran, H.G.; de Los Santos, E.L.C.; Kim, H.U.; Nave, M.; et al. antiSMASH 4.0—Improvements in chemistry prediction and gene cluster boundary identification. Nucleic Acids Res 2017, 45, W36–W41. [CrossRef] [PubMed]
123. Reddy, B.V.B.; Milshteyn, A.; Charlop-Powers, Z.; Brady, S.F. eSNaPD: A versatile, web-based bioinformatics platform for surveying and mining natural product biosynthetic diversity from metagenomes. Chem. Biol. 2014, 21, 1023–1033. [CrossRef] [PubMed]
124. Ziemert, N.; Podell, S.; Penn, K.; Badger, J.H.; Allen, E.; Jensen, P.R. The natural product domain seeker NaPDoS: A phylogeny based bioinformatic tool to classify secondary metabolite gene diversity. PLoS ONE 2012, 7, e34064. [CrossRef] [PubMed]
125. Owen, J.G.; Reddy, B.V.; Ternei, M.A.; Charlop-Powers, Z.; Calle, P.Y.; Kim, J.H.; Brady, S.F. Mapping gene clusters within arrayed metagenomic libraries to expand the structural diversity of biomedically relevant natural products. Proc. Natl. Acad. Sci. USA 2013, 110, 11797–11802. [CrossRef] [PubMed]
126. Charlop-Powers, Z.; Milshteyn, A.; Brady, S.F. Metagenomic small molecule discovery methods. Curr. Opin. Microbiol. 2014, 0, 70–75. [CrossRef] [PubMed]
127. Woodhouse, J.N.; Fan, L.; Brown, M.V.; Thomas, T.; Neilan, B.A. Deep sequencing of non-ribosomal peptide synthetases and polyketide synthases from the microbiomes of Australian marine sponges. ISME J. 2013, 7, 1842–1851. [CrossRef] [PubMed]
128. Niu, G.; Tan, H. Nucleoside antibiotics: Biosynthesis, regulation, and biotechnology. Trends Microbiol. 2015, 23, 110–119. [CrossRef] [PubMed]
129. Feng, Z.Y.; Kallifidas, D.; Brady, S.F. Functional analysis of environmental DNA-derived type II polyketide synthases reveals structurally diverse secondary metabolites. Proc. Natl. Acad. Sci. USA 2011, 108, 12629–12634. [CrossRef] [PubMed]
130. Banik, J.J.; Craig, J.W.; Calle, P.Y.; Brady, S.F. Tailoring enzyme-rich environmental DNA clones: A source of enzymes for generating libraries of unnatural natural products. J. Am. Chem. Soc. 2010, 132, 15661–15670. [CrossRef] [PubMed]
131. Yao, J.; Fan, X.J.; Lu, Y.; Liu, Y.H. Isolation and characterization of a novel tannase from a metagenomic library. J. Agric. Food Chem. 2011, 59, 3812–3818. [CrossRef] [PubMed]
132. Wang, Q.; Wu, H.; Wang, A.; Du, P.; Pei, X.; Li, H.; Yin, X.; Huang, L.; Xiong, X. Prospecting metagenomic enzyme subfamily genes for DNA family shuffling by a novel PCR-based approach. J. Biol. Chem. 2010, 285, 41509–41516. [CrossRef] [PubMed]
133. Wang, K.; Li, G.; Yu, S.Q.; Zhang, C.T.; Liu, Y.H. A novel metagenome-derived _-galactosidase: Gene cloning, overexpression, purification and characterization. Appl. Microbiol. Biotechnol. 2010, 88, 155–165. [CrossRef] [PubMed]
134. Brady, S.F.; Bauer, J.D.; Clarke-Pearson, M.F.; Daniels, R. Natural products from isnA-containing biosynthetic gene clusters recovered from the genomes of cultured and uncultured bacteria. J. Am. Chem. Soc. 2007, 129, 12102–12103. [CrossRef] [PubMed]
135. Chang, F.-Y.; Ternei, M.A.; Calle, P.Y.; Brady, S.F. Targeted metagenomics: Finding rare tryptophan dimer natural products in the environment. J. Am. Chem. Soc. 2015, 137, 6044–6052. [CrossRef] [PubMed]
136. Kang, H.-S.; Brady, S.F. Arimetamycin A: Improving clinically relevant families of natural products through sequence-guided screening of soil metagenomes. Angew. Chem. Int. Ed. 2013, 52, 11063–11067. [CrossRef] [PubMed]
137. Kallifidas, D.; Kang, H.-S.; Brady, S.F. Tetarimycin A, an MRSA-active antibiotic identified through induced expression of environmental DNA gene clusters. J. Am. Chem. Soc. 2012, 134, 19552–19555. [CrossRef] [PubMed]
138. Hover, B.M.; Kim, S.-H.; Katz, M.; Charlop-Powers, Z.; Owen, J.G.; Ternei, M.A.; Maniko, J.; Estrela, A.B.; Molina, H.; Park, S.; et al. Culture-independent discovery of the malacidins as calcium-dependent antibiotics with activity against multidrug-resistant Gram-positive pathogens. Nat. Microbiol. 2018, 3, 415–422. [CrossRef] [PubMed]
139. Kallifidas, D.; Jiang, G.; Ding, Y.; Luesch, H. Rational engineering of Streptomyces albus J1074 for the overexpression of secondary metabolite gene clusters. Microb. Cell Fact. 2018, 17. [CrossRef] [PubMed]
140. Leis, B.; Angelov, A.; Liebl, W. Screening and expression of genes from metagenomes. Adv. Appl. Microbiol. 2013, 83, 1–68. [PubMed]
141. Montaser, R.; Luesch, H. Marine natural products: A new wave of drugs? Future Med. Chem. 2011, 3, 1475–1489. [CrossRef] [PubMed]
142. Towbin, H.; Bair, K.W.; DeCaprio, J.A.; Eck, M.J.; Kim, S.; Kinder, F.R.; Morollo, A.; Mueller, D.R.; Schindler, P.; Song, H.K.; et al. Proteomics-based target identification—Bengamides as a new class of methionine aminopeptidase inhibitors. J. Biol. Chem. 2003, 278, 52964–52971. [CrossRef] [PubMed]
143. Wenzel, S.C.; Hoffmann, H.; Zhang, J.; Debussche, L.; Haag-Richter, S.; Kurz, M.; Nardi, F.; Lukat, P.; Kochems, I.; Tietgen, H.; et al. Production of the bengamide class of marine natural products in myxobacteria: Biosynthesis and structure-activity relationships. Angew. Chem. Int. Ed. Engl. 2015, 54, 15560–15564. [CrossRef] [PubMed]
144. Quinoa, E.; Adamczeski, M.; Crews, P.; Bakus, G.J. Bengamides, heterocyclic anthelmintics from a Jaspidae marine sponge. J. Org. Chem. 1986, 51, 4494–4497. [CrossRef]
145. Piel, J. Metabolites from symbiotic bacteria. Nat. Prod. Rep. 2009, 26, 338–362. [CrossRef] [PubMed]
146. Bewley, C.A.; Debitus, C.; Faulkner, D.J. Microsclerodermins A and B. Antifungal cyclic peptides from the lithistid sponge Microscleroderma sp. J. Am. Chem. Soc. 1994, 116, 7631–7636. [CrossRef]
147. Schmidt, E.W.; Faulkner, D.J. Microsclerodermins C–E, antifungal cyclic peptides from the lithistid marine sponges Theonella sp. and Microscleroderma sp. Tetrahedron 1998, 54, 3043–3056. [CrossRef]
148. Hoffmann, T.; Müller, S.; Nadmid, S.; Garcia, R.; Müller, R. Microsclerodermins from terrestrial myxobacteria: An intriguing biosynthesis likely connected to a sponge symbiont. J. Am. Chem. Soc. 2013, 45, 16904–16911. [CrossRef] [PubMed]
149. Simister, R.L.; Deines, P.; Botté, E.S.; Webster, N.S.; Taylor, M.W. Sponge-specific clusters revisited: A comprehensive phylogeny of sponge-associated microorganisms. Environ. Microbiol. 2012, 14, 517–524. [CrossRef] [PubMed]
150. Amann, R.I.; Ludwig, W.; Schleifer, K.H. Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbiol. Rev. 1995, 59, 143–169. [PubMed]
151. Hamada, T.; Matsunaga, S.; Yano, G.; Fusetani, N. Polytheonamides A and B, highly cytotoxic, linear polypeptides with unprecedented structural features, from the marine sponge, Theonella swinhoei. J. Am. Chem. Soc. 2005, 127, 110–118. [CrossRef] [PubMed]
152. Inoue, M.; Shinohara, N.; Tanabe, S.; Takahashi, T.; Okura, K.; Itoh, H.; Mizoguchi, Y.; Iida, M.; Lee, N.; Matsuoka, S. Total synthesis of the large non-ribosomal peptide polytheonamide B. Nat. Chem. 2010, 2, 280–285. [CrossRef] [PubMed]
153. Freeman, M.F.; Gurgui, C.; Helf, M.J.; Morinaka, B.I.; Uria, A.R.; Oldham, N.J.; Sahl, H.-G.; Matsunaga, S.; Piel, J. Metagenome mining reveals polytheonamides as posttranslationally modified ribosomal peptides. Science 2012, 338, 387–390. [CrossRef] [PubMed]
154. Freeman, M.F.; Helf, M.J.; Bhushan, A.; Morinaka, B.I.; Piel, J. Seven enzymes create extraordinary molecular complexity in an uncultivated bacterium. Nat. Chem. 2017, 9, 387–395. [CrossRef] [PubMed]
155. Wilson, M.C.; Mori, T.; Rückert, C.; Uria, A.R.; Helf, M.J.; Takada, K.; Gernert, C.; Steffens, U.A.E.; Heycke, N.; Schmitt, S.; et al. An environmental bacterial taxon with a large and distinct metabolic repertoire. Nature 2014, 506. [CrossRef] [PubMed]
156. Kato, Y.; Fusetani, N.; Matsunaga, S.; Hashimoto, K.; Fujita, S.; Furuya, T. Bioactive marine metabolites. Part 16. Calyculin A. A novel antitumor metabolite from the marine sponge Discodermia calyx. J. Am. Chem. Soc. 1986, 108, 2780–2781. [CrossRef]
157. Edrada, R.A.; Ebel, R.; Supriyono, A.; Wray, V.; Schupp, P.; Steube, K.; van Soest, R.; Proksch, P. Swinhoeiamide A, a new highly active calyculin derivative from the marine sponge Theonella swinhoei. J. Nat. Prod. 2002, 65, 1168–1172. [CrossRef] [PubMed]
158. Hrvatin, S.; Piel, J. Rapid isolation of rare clones from highly complex DNA libraries by PCR analysis of liquid gel pools. J. Microbiol. Methods 2007, 68, 434–436. [CrossRef] [PubMed]
159. Wakimoto, T.; Egami, Y.; Nakashima, Y.; Wakimoto, Y.; Mori, T.; Awakawa, T.; Ito, T.; Kenmoku, H.; Asakawa, Y.; Piel, J.; et al. Calyculin biogenesis from a pyrophosphate protoxin produced by a sponge symbiont. Nat. Chem. Biol. 2014, 10. [CrossRef] [PubMed]
160. Repka, L.M.; Chekan, J.R.; Nair, S.K.; Van Der Donk, W.A. Mechanistic understanding of lanthipeptide biosynthetic enzymes. Chem. Rev. 2017, 117, 5457–5520. [CrossRef] [PubMed]
161. Smith, T.E.; Pond, C.D.; Pierce, E.; Harmer, Z.P.; Kwan, J.; Zachariah, M.M.; Harper, M.K.; Wyche, T.P.; Matainaho, T.K.; Bugni, T.S.; et al. Accessing chemical diversity from the uncultivated symbionts of small marine animals. Nat. Chem. Biol. 2018, 14. [CrossRef] [PubMed]
162. Minowa, Y.; Araki, M.; Kanehisa, M. Comprehensive analysis of distinctive polyketide and nonribosomal peptide structural motifs encoded in microbial genomes. J. Mol. Biol. 2007, 368, 1500–1517. [CrossRef] [PubMed]
163. Gawad, C.; Koh, W.; Quake, S.R. Single-cell genome sequencing: Current state of the science. Nat. Rev. Genet. 2016, 17. [CrossRef] [PubMed]
164. Genilloud, O. Actinomycetes: Still a source of novel antibiotics. Nat. Prod. Rep. 2017, 34, 1203–1232. [CrossRef] [PubMed]
165. Herrmann, J.; Fayad, A.A.; Müller, R. Natural products from myxobacteria: Novel metabolites and bioactivities. Nat. Prod. Rep. 2017, 34, 135–160. [CrossRef] [PubMed]
166. Gomez-Escribano, J.P.; Alt, S.; Bibb, M.J. Next generation sequencing of Actinobacteria for the discovery of novel natural products. Mar. Drugs 2016, 14. [CrossRef] [PubMed]
167. Grindberg, R.V.; Ishoey, T.; Brinza, D.; Esquenazi, E.; Coates, R.C.; Liu, W.-T.; Gerwick, L.; Dorrestein, P.C.; Pevzner, P.; Lasken, R.; et al. Single cell genome amplification accelerates identification of the apratoxin biosynthetic pathway from a complex microbial assemblage. PLoS ONE 2011, 6, e18565. [CrossRef] [PubMed]
168. Mason, O.U.; Hazen, T.C.; Borglin, S.; Chain, P.S.G.; Dubinsky, E.A.; Fortney, J.L.; Han, J.; Holman, H.-Y.N.; Hultman, J.; Lamendella, R.; et al. Metagenome, metatranscriptome and single-cell sequencing reveal microbial response to Deepwater Horizon oil spill. ISME J. 2012, 6, 1715–1727. [CrossRef] [PubMed]
169. Engel, K.; Pinnell, L.; Cheng, J.; Charles, T.C.; Neufeld, J.D. Nonlinear electrophoresis for purification of soil DNA for metagenomics. J. Microbiol. Methods 2012, 88, 35–40. [CrossRef] [PubMed]
170. Pel, J.; Broemeling, D.; Mai, L.; Poon, H.-L.; Tropini, G.; Warren, R.L.; Holt, R.A.; Marziali, A. Nonlinear electrophoretic response yields a unique parameter for separation of biomolecules. Proc. Natl. Acad. Sci. USA 2009, 106, 14796–14801. [CrossRef] [PubMed]
171. Liles, M.R.; Williamson, L.L.; Rodbumrer, J.; Torsvik, V.; Goodman, R.M.; Handelsman, J. Recovery, purification, and cloning of high-molecular-weight DNA from soil microorganisms. Appl. Environ. Microbiol. 2008, 74, 3302–3305. [CrossRef] [PubMed]
172. Teeling, H.; Glöckner, F.O. Current opportunities and challenges in microbial metagenome analysis—A bioinformatic perspective. Brief. Bioinform. 2012, 13, 728–742. [CrossRef] [PubMed]
173. Lakey, J.H.; Lea, E.J.; Rudd, B.A.; Wright, H.M.; Hopwood, D.A. A new channel-forming antibiotic from Streptomyces coelicolor A3(2) which requires calcium for its activity. J. Gen. Microbiol. 1983, 129, 3565–3573. [CrossRef] [PubMed]
174. Rudd, B.A.; Hopwood, D.A. A pigmented mycelial antibiotic in Streptomyces coelicolor: Control by a chromosomal gene cluster. J. Gen. Microbiol. 1980, 119, 333–340. [CrossRef] [PubMed]
175. Tsao, S.-W.; Rudd, B.A.M.; He, X.-G.; Chang, C.-J.; Floss, H.G. Identification of a red pigment from Streptomyces coelicolor A3(2) as a mixture of prodigiosin derivatives. J. Antibiot. 1985, 38, 128–131. [CrossRef] [PubMed]
176. Wright, L.F.; Hopwood, D.A. Actinorhodin is a chromosomally-determined antibiotic in Streptomyces coelicolor A3(2). J. Gen. Microbiol. 1976, 96, 289–297. [CrossRef] [PubMed]
177. Medema, M.H.; Blin, K.; Cimermancic, P.; de Jager, V.; Zakrzewski, P.; Fischbach, M.A.; Weber, T.; Takano, E.; Breitling, R. antiSMASH: Rapid identification, annotation and analysis of secondary metabolite biosynthesis gene clusters in bacterial and fungal genome sequences. Nucleic Acids Res. 2011, 39, W339–W346. [CrossRef] [PubMed]
178. Blin, K.; Kazempour, D.; Wohlleben, W.; Weber, T. Improved lanthipeptide detection and prediction for antiSMASH. PLoS ONE 2014, 9, e89420. [CrossRef] [PubMed]
179. Röttig, M.; Medema, M.H.; Blin, K.; Weber, T.; Rausch, C.; Kohlbacher, O. NRPSpredictor2—A web server for predicting NRPS adenylation domain specificity. Nucleic Acids Res. 2011, 39, W362–W367. [CrossRef] [PubMed]
180. Stachelhaus, T.; Mootz, H.D.; Marahiel, M.A. The specificity-conferring code of adenylation domains in nonribosomal peptide synthetases. Chem. Biol. 1999, 6, 493–505. [CrossRef]
181. Yadav, G.; Gokhale, R.S.; Mohanty, D. Computational approach for prediction of domain organization and substrate specificity of modular polyketide synthases. J. Mol. Biol. 2003, 328, 335–363. [CrossRef]
182. Mohimani, H.; Pevzner, P.A. Dereplication, sequencing and identification of peptidic natural products: From genome mining to peptidogenomics to spectral networks. Nat. Prod. Rep. 2016, 33, 73–86. [CrossRef] [PubMed]
183. Mohimani, H.; Liu, W.-T.; Kersten, R.D.; Moore, B.S.; Dorrestein, P.C.; Pevzner, P.A. NRPquest: Coupling mass spectrometry and genome mining for nonribosomal peptide discovery. J. Nat. Prod. 2014, 77, 1902–1909. [CrossRef] [PubMed]
184. Skinnider, M.A.; Merwin, N.J.; Johnston, C.W.; Magarvey, N.A. PRISM 3: Expanded prediction of natural product chemical structures from microbial genomes. Nucleic Acids Res. 2017, 45, W49–W54. [CrossRef] [PubMed]
185. Skinnider, M.A.; Dejong, C.A.; Rees, P.N.; Johnston, C.W.; Li, H.; Webster, A.L.H.; Wyatt, M.A.; Magarvey, N.A. Genomes to natural products PRediction Informatics for Secondary Metabolomes (PRISM). Nucleic Acids Res. 2015, 43, 9645–9662. [CrossRef] [PubMed]
186. Alanjary, M.; Kronmiller, B.; Adamek, M.; Blin, K.; Weber, T.; Huson, D.; Philmus, B.; Ziemert, N. The Antibiotic Resistant Target Seeker (ARTS), an exploration engine for antibiotic cluster prioritization and novel drug target discovery. Nucleic Acids Res. 2017, 45, W42–W48. [CrossRef] [PubMed]
187. Doyle, D.; McDowall, K.J.; Butler, M.J.; Hunter, I.S. Characterization of an oxytetracycline-resistance gene, otrA, of Streptomyces rimosus. Mol. Microbiol. 1991, 5, 2923–2933. [CrossRef] [PubMed]
188. Kling, A.; Lukat, P.; Almeida, D.V.; Bauer, A.; Fontaine, E.; Sordello, S.; Zaburannyi, N.; Herrmann, J.; Wenzel, S.C.; König, C.; et al. Targeting DnaN for tuberculosis therapy using novel griselimycins. Science 2015, 348, 1106–1112. [CrossRef] [PubMed]
189. Huo, L. Synthetic Biotechnology to Study and Engineer Natural Product Biosynthesis in Actinomycetes. Ph.D. Thesis, Saarland University, Saarbrücken, Germany, 2014.
190. Li, X.; Wu, X.; Zhu, J.; Shen, Y. Amexanthomycins A–J, pentangular polyphenols produced by Amycolatopsis mediterranei S699DrifA. Appl. Microbiol. Biotechnol. 2018, 102, 689–702. [CrossRef] [PubMed]
191. Rebets, Y.; Brötz, E.; Tokovenko, B.; Luzhetskyy, A. Actinomycetes biosynthetic potential: How to bridge in silico and in vivo? J. Ind. Microbiol. Biotechnol. 2014, 41, 387–402. [CrossRef] [PubMed]
192. Zerikly, M.; Challis, G.L. Strategies for the discovery of new natural products by genome mining. ChemBioChem 2009, 10, 625–632. [CrossRef] [PubMed]
193. Rigali, S.; Anderssen, S.; Naômé, A.; van Wezel, G.P. Cracking the regulatory code of biosynthetic gene clusters as a strategy for natural product discovery. Biochem. Pharmacol. 2018. [CrossRef] [PubMed]
194. Metsä-Ketelä, M.; Ylihonko, K.; Mäntsälä, P. Partial activation of a silent angucycline-type gene cluster from a rubromycin β producing Streptomyces sp. PGA 64. J. Antibiot. 2004, 57, 502–510. [CrossRef] [PubMed]
195. Bunet, R.; Song, L.; Mendes, M.V.; Corre, C.; Hotel, L.; Rouhier, N.; Framboisier, X.; Leblond, P.; Challis, G.L.; Aigle, B. Characterization and manipulation of the pathway-specific late regulator AlpW reveals Streptomyces ambofaciens as a new producer of kinamycins. J. Bacteriol. 2011, 193, 1142–1153. [CrossRef] [PubMed]
196. Sidda, J.D.; Song, L.; Poon, V.; Al-Bassam, M.; Lazos, O.; Buttner, M.J.; Challis, G.L.; Corre, C. Discovery of a family of -aminobutyrate ureas via rational derepression of a silent bacterial gene cluster. Chem. Sci. 2013, 5, 86–89. [CrossRef]
197. Laureti, L.; Song, L.J.; Huang, S.; Corre, C.; Leblond, P.; Challis, G.L.; Aigle, B. Identification of a bioactive 51-membered macrolide complex by activation of a silent polyketide synthase in Streptomyces ambofaciens. Proc. Natl. Acad. Sci. USA 2011, 108, 6258–6263. [CrossRef] [PubMed]
198. Olano, C.; García, I.; González, A.; Rodriguez, M.; Rozas, D.; Rubio, J.; Sánchez-Hidalgo, M.; Braña, A.F.; Méndez, C.; Salas, J.A. Activation and identification of five clusters for secondary metabolites in Streptomyces albus J 1074. Microb. Biotechnol. 2014, 7, 242–256. [CrossRef] [PubMed]
199. Bode, E.; Brachmann, A.O.; Kegler, C.; Simsek, R.; Dauth, C.; Zhou, Q.; Kaiser, M.; Klemmt, P.; Bode, H.B. Simple “on-demand” production of bioactive natural products. ChemBioChem 2015, 16, 1115–1119. [CrossRef] [PubMed]
200. Siegl, T.; Tokovenko, B.; Myronovskyi, M.; Luzhetskyy, A. Design, construction and characterisation of a synthetic promoter library for fine-tuned gene expression in actinomycetes. Metab. Eng. 2013, 19, 98–106. [CrossRef] [PubMed]
201. Seghezzi, N.; Amar, P.; Koebmann, B.; Jensen, P.R.; Virolle, M.-J. The construction of a library of synthetic promoters revealed some specific features of strong Streptomyces promoters. Appl. Microbiol. Biotechnol. 2011, 90, 615–623. [CrossRef] [PubMed]
202. Baltz, R.H. Genetic manipulation of secondary metabolite biosynthesis for improved production in Streptomyces and other actinomycetes. J. Ind. Microbiol. Biotechnol. 2016, 43, 343–370. [CrossRef] [PubMed]
203. Zaburannyi, N.; Rabyk, M.; Ostash, B.; Fedorenko, V.; Luzhetskyy, A. Insights into naturally minimised Streptomyces albus J1074 genome. BMC Genom. 2014, 15. [CrossRef] [PubMed]
204. Gomez-Escribano, J.P.; Bibb, M.J. Engineering Streptomyces coelicolor for heterologous expression of secondary metabolite gene clusters. Microb. Biotechnol. 2011, 4, 207–215. [CrossRef] [PubMed]
205. Okada, B.K.; Seyedsayamdost, M.R. Antibiotic dialogues: Induction of silent biosynthetic gene clusters by exogenous small molecules. FEMS Microbiol. Rev. 2017, 41, 19–33. [CrossRef] [PubMed]
206. Rutledge, P.J.; Challis, G.L. Discovery of microbial natural products by activation of silent biosynthetic gene clusters. Nat. Rev. Microbiol. 2015, 13, 509–523. [CrossRef] [PubMed]
207. Seyedsayamdost, M.R. High-throughput platform for the discovery of elicitors of silent bacterial gene clusters. Proc. Natl. Acad. Sci. USA 2014, 111, 7266–7271. [CrossRef] [PubMed]
208. Locatelli, F.M.; Goo, K.-S.; Ulanova, D. Effects of trace metal ions on secondary metabolism and the morphological development of streptomycetes. Metallomics 2016, 8, 469–480. [CrossRef] [PubMed]
209. Hosaka, T.; Ohnishi-Kameyama, M.; Muramatsu, H.; Murakami, K.; Tsurumi, Y.; Kodani, S.; Yoshida, M.; Fujie, A.; Ochi, K. Antibacterial discovery in actinomycetes strains with mutations in RNA polymerase or ribosomal protein S12. Nat. Biotechnol. 2009, 27, 462–464. [CrossRef] [PubMed]
210. Tanaka, Y.; Kasahara, K.; Hirose, Y.; Murakami, K.; Kugimiya, R.; Ochi, K. Activation and products of the cryptic secondary metabolite biosynthetic gene clusters by rifampin resistance (rpoB) mutations in actinomycetes. J. Bacteriol. 2013, 195, 2959–2970. [CrossRef] [PubMed]
211. Ochi, K.; Hosaka, T. New strategies for drug discovery: Activation of silent or weakly expressed microbial gene clusters. Appl. Microbiol. Biotechnol. 2013, 97, 87–98. [CrossRef] [PubMed]
212. Onaka, H.; Tabata, H.; Igarashi, Y.; Sato, Y.; Furumai, T. Goadsporin, a chemical substance which promotes secondary metabolism and morphogenesis in streptomycetes. I. Purification and Characterization. J. Antibiot. 2001, 54, 1036–1044. [CrossRef] [PubMed]
213. Truong, T.T.; Seyedsayamdost, M.; Greenberg, E.P.; Chandler, J.R. A Burkholderia thailandensis acyl-homoserine lactone-independent orphan luxr homolog that activates production of the cytotoxin malleilactone. J. Bacteriol. 2015, 197, 3456–3462. [CrossRef] [PubMed]
214. Yamanaka, K.; Oikawa, H.; Ogawa, H.O.; Hosono, K.; Shinmachi, F.; Takano, H.; Sakuda, S.; Beppu, T.; Ueda, K. Desferrioxamine E produced by Streptomyces griseus stimulates growth and development of Streptomyces tanashiensis. Microbiology 2005, 151, 2899–2905. [CrossRef] [PubMed]
215. Craney, A.; Ozimok, C.; Pimentel-Elardo, S.M.; Capretta, A.; Nodwell, J.R. Chemical perturbation of secondary metabolism demonstrates important links to primary metabolism. Chem. Biol. 2012, 19, 1020–1027. [CrossRef] [PubMed]
216. Pimentel-Elardo, S.M.; Sørensen, D.; Ho, L.; Ziko, M.; Bueler, S.A.; Lu, S.; Tao, J.; Moser, A.; Lee, R.; Agard, D. et al. Activity-independent discovery of secondary metabolites using chemical elicitation and cheminformatic inference. ACS Chem. Biol. 2015, 10, 2616–2623. [CrossRef] [PubMed]
217. Lombardi, P.M.; Angell, H.D.; Whittington, D.A.; Flynn, E.F.; Rajashankar, K.R.; Christianson, D.W. Structure of prokaryotic polyamine deacetylase reveals evolutionary functional relationships with eukaryotic histone deacetylases. Biochemistry 2011, 50, 1808–1817. [CrossRef] [PubMed]
218. Gacek, A.; Strauss, J. The chromatin code of fungal secondary metabolite gene clusters. Appl. Microbiol. Biotechnol. 2012, 95, 1389–1404. [CrossRef] [PubMed]
219. Katz, L.; Baltz, R.H. Natural product discovery: Past, present, and future. J. Ind. Microbiol. Biotechnol. 2016, 43, 155–176. [CrossRef] [PubMed]
220. Penesyan, A.; Kjelleberg, S.; Egan, S. Development of novel drugs from marine surface associated microorganisms. Mar. Drugs 2010, 8, 438–459. [CrossRef] [PubMed]
221. Chen, R.; Zhang, Q.; Tan, B.; Zheng, L.; Li, H.; Zhu, Y.; Zhang, C. Genome mining and activation of a silent PKS/NRPS gene cluster direct the production of totopotensamides. Org. Lett. 2017, 19, 5697–5700. [CrossRef] [PubMed]
222. Reen, F.J.; Romano, S.; Dobson, A.D.W.; O’Gara, F. The Sound of silence: Activating silent biosynthetic gene clusters in marine microorganisms. Mar. Drugs 2015, 13, 4754–4783. [CrossRef] [PubMed]
223. Thanapipatsiri, A.; Gomez-Escribano, J.P.; Song, L.; Bibb, M.J.; Al-Bassam, M.; Chandra, G.; Thamchaipenet, A.; Challis, G.L.; Bibb, M.J. Discovery of unusual biaryl polyketides by activation of a silent Streptomyces venezuelae biosynthetic gene cluster. Chem Bio Chem 2016, 17, 2189–2198. [CrossRef] [PubMed]
224. Zhang, M.M.; Wong, F.T.; Wang, Y.; Luo, S.; Lim, Y.H.; Heng, E.; Yeo, W.L.; Cobb, R.E.; Enghiad, B.; Ang, E.L. et al. CRISPR-Cas9 strategy for activation of silent Streptomyces biosynthetic gene clusters. Nat. Chem. Biol. 2017. [CrossRef] [PubMed]
225. Challis, G.L. Genome mining for novel natural product discovery. J. Med. Chem. 2008, 51, 2618–2628. [CrossRef] [PubMed]
226. Hubert, J.; Nuzillard, J.-M.; Renault, J.-H. Dereplication strategies in natural product research: How many tools and methodologies behind the same concept? Phytochem. Rev. 2017, 16, 55–95. [CrossRef]
227. Breitling, R.; Ceniceros, A.; Jankevics, A.; Takano, E. Metabolomics for secondary metabolite research. Metabolites 2013, 2013, 1076–1083. [CrossRef] [PubMed]
228. Nguyen, Q.T.; Merlo, M.E.; Medema, M.H.; Jankevics, A.; Breitling, R.; Takano, E. Metabolomics methods for the synthetic biology of secondary metabolism. FEBS Lett. 2012, 586, 2177–2183. [CrossRef] [PubMed]
229. Wolfender, J.-L.; Marti, G.; Ferreira Queiroz, E. Advances in techniques for profiling crude extracts and for the rapid identification of natural products: Dereplication, quality control and metabolomics. Curr. Org. Chem. 2010, 14, 1808–1832. [CrossRef]
230. Hou, Y.; Braun, D.R.; Michel, C.R.; Klassen, J.L.; Adnani, N.; Wyche, T.P.; Bugni, T.S. Microbial strain prioritization using metabolomics tools for the discovery of natural products. Anal. Chem. 2012, 84, 4277–4283. [CrossRef] [PubMed]
231. Liu, W.-T.; Kersten, R.D.; Yang, Y.-L.; Moore, B.S.; Dorrestein, P.C. Imaging mass spectrometry and genome mining via short sequence tagging identified the anti-infective agent arylomycin in Streptomyces roseosporus. J. Am. Chem. Soc. 2011, 133, 18010–18013. [CrossRef] [PubMed]
232. Li, Q.; Chen, X.; Jiang, Y.; Jiang, C. Morphological identification of actinobacteria. In Actinobacteria—Basics and Biotechnological Applications; Dhanasekaran, D., Jiang, Y., Eds.; InTech: Rijeka, Croatia, 2016.
233. Onaka, H.; Mori, Y.; Igarashi, Y.; Furumai, T. Mycolic acid-containing bacteria induce natural-product biosynthesis in Streptomyces species. Appl. Environ. Microbiol. 2011, 77, 400–406. [CrossRef] [PubMed]
234. Yang, Y.L.; Xu, Y.; Straight, P.; Dorrestein, P.C. Translating metabolic exchange with imaging mass spectrometry. Nat. Chem. Biol. 2009, 5, 885–887. [CrossRef] [PubMed]
235. Esquenazi, E.; Yang, Y.L.; Watrous, J.; Gerwick, W.H.; Dorrestein, P.C. Imaging mass spectrometry of natural products. Nat. Prod. Rep. 2009, 26, 1521–1534. [CrossRef] [PubMed]
236. Watrous, J.D.; Dorrestein, P.C. Imaging mass spectrometry in microbiology. Nat. Rev. Microbiol. 2011, 9, 683–694. [CrossRef] [PubMed]
237. Costa, A.B.; Cooks, R.G. Simulation of atmospheric transport and droplet-thin film collisions in desorption electrospray ionization. Chem. Commun. 2007, 3915–3917. [CrossRef] [PubMed]
238. Kersten, R.D.; Yang, Y.L.; Xu, Y.; Cimermancic, P.; Nam, S.J.; Fenical, W.; Fischbach, M.A.; Moore, B.S.; Dorrestein, P.C. A mass spectrometry-guided genome mining approach for natural product peptidogenomics. Nat. Chem. Biol. 2011, 7, 794–802. [CrossRef] [PubMed]
239. Vaidyanathan, S.; Fletcher, J.S.; Goodacre, R.; Lockyer, N.P.; Micklefield, J.; Vickerman, J.C. Subsurface biomolecular imaging of Streptomyces coelicolor using secondary ion mass spectrometry. Anal. Chem. 2008, 80, 1942–1951. [CrossRef] [PubMed]
240. Traxler, M.F.; Watrous, J.D.; Alexandrov, T.; Dorrestein, P.C.; Kolter, R. Interspecies interactions stimulate diversification of the Streptomyces coelicolor secreted metabolome. mBio 2013, 4. [CrossRef] [PubMed]
241. Nguyen, S.N.; Liyu, A.V.; Chu, R.K.; Anderton, C.R.; Laskin, J. Constant-distance mode nanospray desorption electrospray ionization mass spectrometry imaging of biological samples with complex topography. Anal. Chem. 2017, 89, 1131–1137. [CrossRef] [PubMed]
242. Gonzalez, D.J.; Haste, N.M.; Hollands, A.; Fleming, T.C.; Hamby, M.; Pogliano, K.; Nizet, V.; Dorrestein, P.C. Microbial competition between Bacillus subtilis and Staphylococcus aureus monitored by imaging mass spectrometry. Microbiology 2011, 157, 2485–2492. [CrossRef] [PubMed]
243. Barger, S.R.; Hoefler, B.C.; Cubillos-Ruiz, A.; Russell, W.K.; Russell, D.H.; Straight, P.D. Imaging secondary metabolism of Streptomyces sp. Mg1 during cellular lysis and colony degradation of competing Bacillus subtilis. Anton. Leeuwenhoek 2012, 102, 435–445. [CrossRef] [PubMed]
244. Boya, P.C.A.; Fernández-Marín, H.; Mejía, L.C.; Spadafora, C.; Dorrestein, P.C.; Gutiérrez, M. Imaging mass spectrometry and MS/MS molecular networking reveals chemical interactions among cuticular bacteria and pathogenic fungi associated with fungus-growing ants. Sci. Rep. 2017, 7. [CrossRef] [PubMed]
245. Hoefler, B.C.; Stubbendieck, R.M.; Josyula, N.K.; Moisan, S.M.; Schulze, E.M.; Straight, P.D. A link between linearmycin biosynthesis and extracellular vesicle genesis connects specialized metabolism and bacterial membrane physiology. Cell Chem. Biol. 2017, 24, 1238–1249. [CrossRef] [PubMed]
246. Schmitt, E.K.; Moore, C.M.; Krastel, P.; Petersen, F. Natural products as catalysts for innovation: A pharmaceutical industry perspective. Curr. Opin. Chem. Biol. 2011, 15, 497–504. [CrossRef] [PubMed]
247. Exarchou, V.; Krucker, M.; van Beek, T.A.; Vervoort, J.; Gerothanassis, I.P.; Albert, K. LC-NMR coupling technology: Recent advancements and applications in natural products analysis. Magn. Reson. Chem. 2005, 43, 681–687. [CrossRef] [PubMed]
248. Schroeder, F.C.; Gronquist, M. Extending the scope of NMR spectroscopy with microcoil probes. Angew. Chem. Int. Ed. Engl. 2006, 45, 7122–7131. [CrossRef] [PubMed]
249. Iwasa, K.; Takahashi, T.; Nishiyama, Y.; Moriyasu, M.; Sugiura, M.; Takeuchi, A.; Tode, C.; Tokuda, H.; Takeda, K. Online structural elucidation of alkaloids and other constituents in crude extracts and cultured cells of Nandina domestica by combination of LC-MS/MS, LC-NMR, and LC-CD analyses. J. Nat. Prod. 2008, 71, 1376–1385. [CrossRef] [PubMed]
250. Iwasa, K.; Cui, W.; Takahashi, T.; Nishiyama, Y.; Kamigauchi, M.; Koyama, J.; Takeuchi, A.; Moriyasu, M.; Takeda, K. Biotransformation of phenolic tetrahydroprotoberberines in plant cell cultures followed by LC-NMR, LC-MS, and LC-CD. J. Nat. Prod. 2010, 73, 115–122. [CrossRef] [PubMed]
251. Cui, W.; Iwasa, K.; Sugiura, M.; Takeuchi, A.; Tode, C.; Nishiyama, Y.; Moriyasu, M.; Tokuda, H.; Takeda, K. Biotransformation of phenolic 1-benzyl-N-methyltetrahydroisoquinolines in plant cell cultures followed by LC/NMR, LC/MS, and LC/CD. J. Nat. Prod. 2007, 70, 1771–1778. [CrossRef] [PubMed]
252. Exarchou, V.; Fiamegos, Y.C.; van Beek, T.A.; Nanos, C.; Vervoort, J. Hyphenated chromatographic techniques for the rapid screening and identification of antioxidants in methanolic extracts of pharmaceutically used plants. J. Chromatogr. A 2006, 1112, 293–302. [CrossRef] [PubMed]
253. Krucker, M.; Lienau, A.; Putzbach, K.; Grynbaum, M.D.; Schuler, P.; Albert, K. Hyphenation of capillary HPLC to microcoil 1H NMR spectroscopy for the determination of tocopherol homologues. Anal. Chem. 2004, 76, 2623–2628. [CrossRef] [PubMed]
254. Zehl, M.; Braunberger, C.; Conrad, J.; Crnogorac, M.; Krasteva, S.; Vogler, B.; Beifuss, U.; Krenn, L. Identification and quantification of flavonoids and ellagic acid derivatives in therapeutically important Drosera species by LC-DAD, LC-NMR, NMR, and LC-MS. Anal. Bioanal. Chem. 2011, 400, 2565–2576. [CrossRef] [PubMed]
255. Hu, J.-F.; Garo, E.; Yoo, H.-D.; Cremin, P.A.; Goering, M.G.; O’Neil-Johnson, M.; Eldridge, G.R. Cyclolignans from Scyphocephalium ochocoa via high-throughput natural product chemistry methods. Phytochemistry 2005, 66, 1077–1082. [CrossRef] [PubMed]
256. Johansen, K.T.; Wubshet, S.G.; Nyberg, N.T.; Jaroszewski, J.W. From retrospective assessment to prospective decisions in natural product isolation: HPLC-SPE-NMR analysis of Carthamus oxyacantha. J. Nat. Prod. 2011, 74, 2454–2461. [CrossRef] [PubMed]
257. Lang, G.; Mayhudin, N.A.; Mitova, M.I.; Sun, L.; van der, S.S.; Blunt, J.W.; Cole, A.L.; Ellis, G.; Laatsch, H.; Munro, M.H. Evolving trends in the dereplication of natural product extracts: New methodology for rapid, small-scale investigation of natural product extracts. J. Nat. Prod. 2008, 71, 1595–1599. [CrossRef] [PubMed]
258. Keller, L.; Plaza, A.; Dubiella, C.; Groll, M.; Kaiser, M.; Muller, R. Macyranones: Structure, biosynthesis, and binding mode of an unprecedented epoxyketone that targets the 20S proteasome. J. Am. Chem. Soc. 2015, 137, 8121–8130. [CrossRef] [PubMed]
259. Lin, Y.; Schiavo, S.; Orjala, J.; Vouros, P.; Kautz, R. Microscale LC-MS-NMR platform applied to the identification of active cyanobacterial metabolites. Anal. Chem. 2008, 80, 8045–8054. [CrossRef] [PubMed]
260. Pham, L.H.; Vater, J.; Rotard, W.; Mügge, C. Identification of secondary metabolites from Streptomyces violaceoruber TU22 by means of on-flow LC-NMR and LC-DAD-MS. Magn. Reson. Chem. 2005, 43, 710–723. [CrossRef] [PubMed]
261. Alshaibani, M.; Zin, N.; Jalil, J.; Sidik, N.; Ahmad, S.J.; Kamal, N.; Edrada-Ebel, R. Isolation, purification, and characterization of five active diketopiperazine derivatives from endophytic Streptomyces SUK 25 with antimicrobial and cytotoxic activities. J. Microbiol. Biotechnol. 2017, 27, 1249–1256. [CrossRef] [PubMed]
262. Shah, A.; Rather, M.A.; Hassan, Q.P.; Aga, M.A.; Mushtaq, S.; Shah, A.M.; Hussain, A.; Baba, S.A.; Ahmad, Z. Discovery of anti-microbial and anti-tubercular molecules from Fusarium solani: An endophyte of Glycyrrhiza glabra. J. Appl. Microbiol. 2017, 122, 1168–1176. [CrossRef] [PubMed]
263. Greule, A.; Zhang, S.; Paululat, T.; Bechthold, A. From a natural product to its biosynthetic gene cluster: a demonstration using polyketomycin from Streptomyces diastatochromogenes Tü6028. J. Vis. Exp. 2017. [CrossRef] [PubMed]
264. Gibitz Eisath, N.; Sturm, S.; Stuppner, H. Supercritical fluid chromatography in natural product analysis—An update. Planta Med. 2017. [CrossRef] [PubMed]
265. Khater, S.; Lozac’h, M.-A.; Adam, I.; Francotte, E.; West, C. Comparison of liquid and supercritical fluid chromatography mobile phases for enantioselective separations on polysaccharide stationary phases. J. Chromatogr. A 2016, 1467, 463–472. [CrossRef] [PubMed]
266. De Klerck, K.; Mangelings, D.; Vander Heyden, Y. Supercritical fluid chromatography for the enantioseparation of pharmaceuticals. J. Pharm. Biomed. Anal. 2012, 69, 77–92. [CrossRef] [PubMed]
267. Novakova, L.; Perrenoud, A.G.-G.; Francois, I.; West, C.; Lesellier, E.; Guillarme, D. Modern analytical supercritical fluid chromatography using columns packed with sub-2 μm particles: A tutorial. Anal. Chim. Acta 2014, 824, 18–35. [CrossRef] [PubMed]
268. Lesellier, E.; West, C. The many faces of packed column supercritical fluid chromatography—A critical review. J. Chromatogr. A 2015, 1382, 2–46. [CrossRef] [PubMed]
269. West, C.; Lemasson, E.; Bertin, S.; Hennig, P.; Lesellier, E. An improved classification of stationary phases for ultra-high performance supercritical fluid chromatography. J. Chromatogr. A 2016, 1440, 212–228. [CrossRef] [PubMed]
270. Wang, M.; Carrell, E.J.; Chittiboyina, A.G.; Avula, B.; Wang, Y.-H.; Zhao, J.; Parcher, J.F.; Khan, I.A. Concurrent supercritical fluid chromatographic analysis of terpene lactones and ginkgolic acids in Ginkgo biloba extracts and dietary supplements. Anal. Bioanal. Chem. 2016, 408, 4649–4660. [CrossRef] [PubMed]
271. Huang, Y.; Feng, Y.; Tang, G.; Li, M.; Zhang, T.; Fillet, M.; Crommen, J.; Jiang, Z. Development and validation of a fast SFC method for the analysis of flavonoids in plant extracts. J. Pharm. Biomed. Anal. 2017, 140, 384–391. [CrossRef] [PubMed]
272. Vicente, G.; García-Risco, M.R.; Fornari, T.; Reglero, G. Isolation of carnosic acid from rosemary extracts using semi-preparative supercritical fluid chromatography. J. Chromatogr. A 2013, 1286, 208–215. [CrossRef] [PubMed]
273. Salimi, A.; Fatemi, S.; Zakizadeh Nei Nei, H.; Safaralie, A. Mathematical modeling of supercritical extraction of valerenic acid from Valeriana officinalis L. Chem. Eng. Technol. 2008, 31, 1470–1480. [CrossRef]
274. Ramsden, J.J. Metabolomics and metabonomics. In Bioinformatics: An Introduction, 2nd ed.; Ramsden, J., Ed.; Springer: New York, NY, USA, 2009; pp. 1–6.
275. Mohamed, A.; Nguyen, C.H.; Mamitsuka, H. Current status and prospects of computational resources for natural product dereplication: A review. Brief. Bioinform. 2016, 17, 309–321. [CrossRef] [PubMed]
276. Beutler, J.A.; Alvarado, A.B.; Schaufelberger, D.E.; Andrews, P.; McCloud, T.G. Dereplication of phorbol bioactives: Lyngbya majuscula and Croton cuneatus. J. Nat. Prod. 1990, 53, 867–874. [CrossRef] [PubMed]
277. Chanana, S.; Thomas, C.S.; Braun, D.R.; Hou, Y.; Wyche, T.P.; Bugni, T.S. Natural product discovery using planes of principal component analysis in R (PoPCAR). Metabolites 2017, 7. [CrossRef] [PubMed]
278. Bitzer, J.; Köpcke, B.; Stadler, M.; Hellwig, V.; Ju, Y.-M.; Seip, S.; Henkel, T. Accelerated dereplication of natural products, supported by reference libraries. CHIMIA 2007, 61, 332–338. [CrossRef]
279. Dictionary of Natural Products. Available online: http://dnp.chemnetbase.com/faces/chemical/ ChemicalSearch.xhtml (accessed on 31 January 2018).
280. Laatsch, H. AntiBase 2014: The Natural Compound Identifier; Wiley-VCH: Weinheim, Germany, 2014.
281. Blunt, J.W.; Copp, B.R.; Keyzers, R.A.; Munro, M.H.G.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2017, 34, 235–294. [CrossRef] [PubMed]
282. Horai, H.; Arita, M.; Kanaya, S.; Nihei, Y.; Ikeda, T.; Suwa, K.; Ojima, Y.; Tanaka, K.; Tanaka, S.; Aoshima, K. et al. MassBank: A public repository for sharing mass spectral data for life sciences. J. Mass Spectrom. 2010, 45, 703–714. [CrossRef] [PubMed]
283. Smith, C.A.; O’Maille, G.; Want, E.J.; Qin, C.; Trauger, S.A.; Brandon, T.R.; Custodio, D.E.; Abagyan, R.; Siuzdak, G. METLIN: A metabolite mass spectral database. Ther. Drug Monit. 2005, 27, 747–751. [CrossRef] [PubMed]
284. mzCloud: Advanced Mass Spectral Database. Available online: https://www.mzcloud.org/ (accessed on 10 May 2018).
285. Sawada, Y.; Nakabayashi, R.; Yamada, Y.; Suzuki, M.; Sato, M.; Sakata, A.; Akiyama, K.; Sakurai, T.; Matsuda, F.; Aoki, T. et al. RIKEN tandem mass spectral database (ReSpect) for phytochemicals: A plant-specific MS/MS-based data resource and database. Phytochemistry 2012, 82, 38–45. [CrossRef] [PubMed]
286. Johnston, C.W.; Skinnider, M.A.; Wyatt, M.A.; Li, X.; Ranieri, M.R.M.; Yang, L.; Zechel, D.L.; Ma, B.; Magarvey, N.A. An automated Genomes-to-Natural Products platform (GNP) for the discovery of modular natural products. Nat. Commun. 2015, 6. [CrossRef] [PubMed]
287. Wang, M.; Carver, J.J.; Phelan, V.V.; Sanchez, L.M.; Garg, N.; Peng, Y.; Nguyen, D.D.; Watrous, J.; Kapono, C.A.; Luzzatto-Knaan, T. et al. Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking. Nat. Biotechnol. 2016, 34, 828–837. [CrossRef] [PubMed]
288. Crüsemann, M.; O’Neill, E.C.; Larson, C.B.; Melnik, A.V.; Floros, D.J.; da Silva, R.R.; Jensen, P.R.; Dorrestein, P.C.; Moore, B.S. Prioritizing natural product diversity in a collection of 146 bacterial strains based on growth and extraction protocols. J. Nat. Prod. 2016. [CrossRef] [PubMed]
289. Mohimani, H.; Gurevich, A.; Mikheenko, A.; Garg, N.; Nothias, L.-F.; Ninomiya, A.; Takada, K.; Dorrestein, P.C.; Pevzner, P.A. Dereplication of peptidic natural products through database search of mass spectra. Nat. Chem. Biol. 2017, 13, 30–37. [CrossRef] [PubMed]
290. Gurevich, A.; Mikheenko, A.; Shlemov, A.; Korobeynikov, A.; Mohimani, H.; Pevzner, P.A. Increased diversity of peptidic natural products revealed by modification-tolerant database search of mass spectra. Nat. Microbiol. 2018. [CrossRef] [PubMed]
291. Zierep, P.F.; Padilla, N.; Yonchev, D.G.; Telukunta, K.K.; Klementz, D.; Günther, S. SeMPI: A genome-based secondary metabolite prediction and identification web server. Nucleic Acids Res. 2017, 45, W64–W71. [CrossRef] [PubMed]
292. Blin, K.; Medema, M.H.; Kazempour, D.; Fischbach, M.A.; Breitling, R.; Takano, E.; Weber, T. antiSMASH 2.0—A versatile platform for genome mining of secondary metabolite producers. Nucleic Acids Res. 2013, 41, W204–W212. [CrossRef] [PubMed]
293. Medema, M.H.; Paalvast, Y.; Nguyen, D.D.; Melnik, A.; Dorrestein, P.C.; Takano, E.; Breitling, R. Pep2Path: Automated mass spectrometry-guided genome mining of peptidic natural products. PLoS Comput. Biol. 2014, 10, e1003822. [CrossRef] [PubMed]
294. Mohimani, H.; Kersten, R.D.; Liu, W.-T.; Wang, M.; Purvine, S.O.; Wu, S.; Brewer, H.M.; Pasa-Tolic, L.; Bandeira, N.; Moore, B.S. et al. Automated genome mining of ribosomal peptide natural products. ACS Chem. Biol. 2014, 9, 1545–1551. [CrossRef] [PubMed]
295. Blin, K.; Medema, M.H.; Kottmann, R.; Lee, S.Y.; Weber, T. The antiSMASH database, a comprehensive database of microbial secondary metabolite biosynthetic gene clusters. Nucleic Acids Res. 2017, 45, D555–D559. [CrossRef] [PubMed]
296. Liu, W.T.; Lamsa, A.; Wong, W.R.; Boudreau, P.D.; Kersten, R.; Peng, Y.; Moree, W.J.; Duggan, B.M.; Moore, B.S.; Gerwick, W.H. et al. MS/MS-based networking and peptidogenomics guided genome mining revealed the stenothricin gene cluster in Streptomyces roseosporus. J. Antibiot. 2014, 67, 99–104. [CrossRef] [PubMed]
297. Udwary, D.W.; Zeigler, L.; Asolkar, R.N.; Singan, V.; Lapidus, A.; Fenical, W.; Jensen, P.R.; Moore, B.S. Genome sequencing reveals complex secondary metabolome in the marine actinomycete Salinispora tropica. Proc. Natl. Acad. Sci. USA 2007, 104, 10376–10381. [CrossRef] [PubMed]
298. Kjaerulff, L.; Sikandar, A.; Zaburannyi, N.; Adam, S.; Herrmann, J.; Koehnke, J.; Müller, R. Thioholgamides: Thioamide-containing cytotoxic RiPPs natural products. ACS Chem. Biol. 2017, 12, 2837–2841. [CrossRef] [PubMed]
299. Salvador-Reyes, L.A.; Luesch, H. Biological targets and mechanisms of action of natural products from marine cyanobacteria. Nat. Prod. Rep. 2015, 32, 478–503. [CrossRef] [PubMed]
300. Wenzel, S.C.; Müller, R. Myxobacteria—Unique microbial secondary metabolite factories. In Comprehensive Natural Products Chemistry II, Vol 2: Structural Diversity II—Secondary Metabolite Sources, Evolution and Selected Molecular Structures; Moore, B.S., Ed.; Elsevier: Oxford, UK, 2010; pp. 189–222.
301. Tiwari, K.; Gupta, R.K. Rare actinomycetes: A potential storehouse for novel antibiotics. Crit. Rev. Biotechnol. 2012, 32, 108–132. [CrossRef] [PubMed]
302. Jensen, P.R. Natural products and the gene cluster revolution. Trends Microbiol. 2016, 24, 968–977. [CrossRef] [PubMed]
303. Goss, R.J.M.; Shankar, S.; Fayad, A.A. The generation of “unnatural” products: Synthetic biology meets synthetic chemistry. Nat. Prod. Rep. 2012, 29, 870–889.
304. Smanski, M.J.; Zhou, H.; Claesen, J.; Shen, B.; Fischbach, M.A.; Voigt, C.A. Synthetic biology to access and expand nature’s chemical diversity. Nat. Rev. Microbiol. 2016, 14, 135–149. [CrossRef] [PubMed]